WuXi AppTec sees growth af­ter 2024 dip, plans ‘lean’ op­er­a­tions to tem­per ‘ex­ter­nal op­por­tu­ni­ties’

5 weeks ago
China
Pharma

Bio­haven gets an up to $600M in­vest­ment; Prile­nia, Fer­rer make a deal in Eu­rope

5 weeks ago
News Briefing

Schol­ar Rock names new CEO, adds biotech vet­er­ans in C-suite re­build

5 weeks ago
People

Dai­ichi Sankyo says pro­duc­tion boost in US will help cush­ion tar­iff im­pact

5 weeks ago
Pharma
Manufacturing

Boehringer’s up­dat­ed re­sults in HER2-mu­tat­ed lung can­cer im­press

5 weeks ago
R&D

Mer­ck KGaA to buy rare can­cer biotech Spring­Works for $3.9B

5 weeks ago
Deals
Pharma

Eu­ro­pean reg­u­la­tors rec­om­mend new drugs from Ver­tex, Am­gen and Jazz 

5 weeks ago
Pharma
FDA+

France stops Val­neva's chikun­gun­ya vac­cine roll­out in over 65s af­ter safe­ty is­sue

5 weeks ago
Pharma

Ex­clu­sive: Can AI re­place an­i­mal test­ing? A new biotech launch­es to find out

5 weeks ago
Financing
AI

GSK’s check­point block­er Jem­per­li cures bio­mark­er-dri­ven rec­tal can­cer

5 weeks ago
R&D
Pharma

Keytru­da around head and neck can­cer surgery cuts chance of dis­ease com­ing back

5 weeks ago
R&D

Rev­o­lu­tion Med­i­ci­nes' KRAS drug shows po­ten­tial in ear­ly cut of lung can­cer da­ta

5 weeks ago
R&D

J&J re­ports dura­bil­i­ty da­ta for blad­der can­cer 'pret­zel' drug af­ter FDA fil­ing

Last month
R&D

Earn­ings sea­son is up­on us; Makary on rare dis­ease; Start­up is first to in­ject CRISPR in the brain; and more

Last month
Weekly

FDA chief Makary talks ex­pe­dit­ing drug ap­provals, RIFs and the abor­tion pill

Last month
R&D
Pharma

Ab­b­Vie com­mits $10B to ex­pand US foot­print with the threat of tar­iffs ahead

Last month
Pharma
Manufacturing

Am­gen in­vests $900M to ex­pand Ohio bio­man­u­fac­tur­ing

Last month
Manufacturing

Com­pound­ing phar­ma­cies dealt a blow in fight over end of semaglu­tide short­age

Last month
Pharma
Law

RFK Jr. touts CMS pro­gram test­ing new ways to pay for sick­le cell dis­ease treat­ment

Last month
Pharma
Cell/Gene Tx

Ake­so shares new da­ta sug­gest­ing it can beat Keytru­da on sur­vival, wins Chi­na ap­proval

Last month
R&D
China

Hop­ing to turn CD47 around with Keytru­da com­bo, ALX On­col­o­gy re­ports two Phase 2 fail­ures

Last month
R&D

New fund will pres­sure flail­ing biotechs, as in­vestor frus­tra­tion boils over

Last month
Financing
Deals

Lil­ly asks EU reg­u­la­tor to re­vis­it Kisun­la; CHMP rec­om­mends PTC's PKU drug

Last month
News Briefing

Ab­b­Vie's im­munol­o­gy fran­chise re­mains a pow­er­house, as Skyrizi, Rin­voq com­bine for $5B

Last month
Pharma
First page Previous page 10111213141516 Next page Last page
A service from the Financial Times